Unlikely to cause harm — often a labeling or packaging issue.
Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine
| Distributed by / for | SUN PHARMACEUTICAL INDUSTRIES INC |
| NDC | 57664-783-86 |
| Full product label | Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, 60-count bottle, Rx only, Mfg by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-783-86 |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide USA |
| Quantity | 3516 bottles |
| Recall initiated | 2020-07-06 |
| Report date | 2020-08-05 |
| Recall completed | 2023-06-08 |
| Recall number | D-1445-2020 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗